Cannabis
Circadian Wellness Inc. Chief Operating Officer Will Present at a Psychedelic Capital Event Hosted by Microdose(TM)
Toronto, Ontario–(Newsfile Corp. – May 31, 2021) – Today, functional mushroom company Circadian Wellness will have a member of their leadership team presenting at the virtual Psychedelic Capital event hosted by MicroDose™. Chief Operating Officer, Alex Wolfe will be providing his perspective about the functional and psychedelic mushroom landscape and the future of the industry.
“We are delighted to share our perspective, learn and support fellow industry leaders in a unique event. We all share the same mission – to educate and bring the benefits of microdosing to more people,” said Alex Wolfe, Chief Operating Officer at Circadian Wellness.
Also on the horizon for the wellness company is the commencement of a clinical study testing a novel sleep supplement through a sublingual liposomal delivery format (Quicksome™). The purpose of the study is to explore the effects of the supplement on quality of sleep, and the potential of the delivery method by monitoring patients’ sleep metrics.
The prospective clinical study has 30 participants in a double-blind randomized trial over a two-month period. Researchers are using the oura ring, a smart sleep tracking device to collect data related to additional vitals including deep sleep, REM sleep, lowest resting heart rate, mean heart rate variability, and total sleep time. The study is under the supervision of esteemed holistic wellness expert, Dr. Sanjeev Goel, Chief Medical Officer to Circadian Wellness and founder of Peak Human brands.
About Circadian Wellness Inc.
Circadian Wellness Inc. (CW) is bringing functional mushroom products to market. The company focuses on mushroom farming, extraction and patented delivery methods to manufacture and brand various health and wellness products. Since inception, research breakthroughs have made their licensed proprietary Quicksome™ delivery system scalable commercially by delivering the highest purity and quality mushroom extracts and isolates.
For more information or to arrange an interview, please contact:
647-522-2176
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/85862
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE4 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis3 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt3 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace